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2. One issue discussed by the authors is the potential skewing due to their tertiary centre status. Has their pattern of overall patient recruitment (not just coeliac disease) changed during this time period?
3. The data on challenge testing (Table 2) is interesting, as the rate of positive clinical findings in the later cohort is similar to the older cohort, despite the less striking presentation at diagnosis. Perhaps a little more detail about this in the text would be helpful.
4. I would appreciate more details about the silent patients, ie the 8 without symptoms. Did all have normal miconutrient status, normal biopsies and low-titre tTG antibodies ? It is probably the most difficult area, and clarity of definition would be very helpful.
5 It would be helpful for the authors to be more explicit about their recommended management of silent coeliac disease (ie what would be the minimal changes with time that should trigger later introduction of a gluten-free diet?).
REVIEWER
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GENERAL COMMENTS
In this study Garnier-Lengline et al hypothesize that the introduction of serological testing for coeliac disease has changed the phenotype of the condition at presentation. They have used historical controls and have acknowledged that this approach does have limitations. The study period extends over a period which includes the introduction of anti-gliadin antibody, anti-endomysial antibody and anti tissue transglutaminase antibody tests, the introduction of the ESPGHAN diagnostic criteria and their revision, and the replacement of the Crosby capsule biopsy technique with endoscopic biopsy. The manuscript does not state when these changes were incorporated into the practice at the Necker Hospital.
The study deliberately includes asymptomatic patients diagnosed following antibody screening in the modern cohort. The inclusion of these patients in the study group introduces a systemic bias into the study, and whilst it is of interest that this group is included in the population of the clinic's patients, it is not valid to conduct a comparison between a modern group containing screened patients and a historic group without any screened patients.
There is much data presented in the manuscript, not all of which is relevant to the hypothesis being tested. In particular the paragraph headed "serological tests" and the data on gluten challenge do not contribute.
Regarding the data presented, failure to thrive is not defined. Data on Iron and albumin is said to have been collected, but is not presented. Data on Hb and folate is from a sub-population of each cohort and it is unclear how patients were selected for Hb and folate measurement. IgA deficiency is mentioned in a table but not in the results section
More minor points concern presentation and would relate to FrancoEnglish translation. The decimal separator would usually be a dot. In several places the grammatic syntax is a literal translation from French and review of this would improve the ability of the manuscript to communicate with an English speaking readership. Particular examples are "neither significant" in serological… , "resumed" in the family history paragraph, and "This study comprised…" in the discussion.
In summary the study design does not allow causality to be determined and therefore the conclusion drawn at the end of the discussion can not be justified. The effects of the presence of screened patients in the modern cohort is not sufficiently described, so that the reader can not easily appreciate the small magnitude of the difference between historic and modern symptomatic cohorts. More comment could be made on the likelihood that these small changes result from referral bias in a single physician population or from confounding variables. There is specific value in the description of outcomes in the screened patients maintained on a gluten containing diet, but this is not relevant to the hypothesis being tested.
VERSION 1 -AUTHOR RESPONSE
This study, from a major French tertiary centre, tracks the changes in presentation of coeliac disease that have occurred since the advent of specific serological testing. The centre has published a number of classical studies on coeliac disease. The findings overall are similar to those from a number of other countries, with a shift towards less florid presentation likely due to identification of cases that would have previously been overlooked. My one concern is whether this study adds new insights to the published literature -it would be helpful if the authors stated where their findings differ from the cited reports from other countries.
Specific points 1. The endomysial antibody was first reported in 1984, and not the early 1990's as stated.
I totally agree with the reviewer one on this point. I did not mention in my manuscript that the endomysial antibodies were reported in the early 1990's, but that they were commonly used since these years.
No, the pattern of overall patient recruitment did not change in Necker-Enfants Malades hospital during this period. Thus the skewing due to the belonging of patients to a tertiary centre should not be of major importance (patients of both cohorts had the same bias).
Silent patients had normal micronutrient status, but sometimes their antibody titers were high. Biopsies were not always performed. When they were performed, patients were considered as silent even if there was a villous atrophy. In the literature, celiac patients are considered as "silent" patients when they have positive serological tests and lesions on duodenal biopsies (villous atrophy) but without developing any symptom or micronutrient deficiency (vitamins, iron…).
silent coeliac disease (ie what would be the minimal changes with time that should trigger later introduction of a gluten-free diet?).
I agree with remarks 3 and 5. When it was possible, I added some data about challenge testing and silent patients in my manuscript.
Reviewer: 2
Comments to the Author In this study Garnier-Lengline et al hypothesize that the introduction of serological testing for coeliac disease has changed the phenotype of the condition at presentation. They have used historical controls and have acknowledged that this approach does have limitations. The study period extends over a period which includes the introduction of anti-gliadin antibody, anti-endomysial antibody and anti tissue transglutaminase antibody tests, the introduction of the ESPGHAN diagnostic criteria and their revision, and the replacement of the Crosby capsule biopsy technique with endoscopic biopsy. The manuscript does not state when these changes were incorporated into the practice at the Necker Hospital.
The aim of the study was to try to identify if the use of serological tests had changed the profile of celiac disease. I have separated the recent cohort in two groups, one comparable to the historical cohort (symptomatic patients) and the second one consisting of screened patients. This distinction could allow me to compare the patients of both cohorts, even if there was no screened patient in the historical cohort.
I let the data about the gluten challenge in my manuscript but I removed the paragraph "serological tests".
Regarding the data presented, failure to thrive is not defined. Data on Iron and albumin is said to have been collected, but is not presented. Data on Hb and folate is from a sub-population of each cohort and it is unclear how patients were selected for Hb and folate measurement. IgA deficiency is mentioned in a table but not in the results section I have corrected these details and added some precisions about the definition of "failure to thrive" .
More minor points concern presentation and would relate to Franco-English translation. The decimal separator would usually be a dot. In several places the grammatic syntax is a literal translation from French and review of this would improve the ability of the manuscript to communicate with an English speaking readership. Particular examples are "neither significant" in serological… , "resumed" in the family history paragraph, and "This study comprised…" in the discussion.
Thanks for those useful remarks. I have tried to correct all mistakes.
